jRCT1010260034招募中不适用
Determination of the Optimal Load for Repeated Sprint Cycling
未提供0 个研究点目标入组 21 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- Male
入选标准
- •Engages in physical exercise at least twice per week
- •No prior experience in competitive cycling
- •No musculoskeletal injuries that could interfere with the repeated sprint cycling performed in this study at the time of participation
- •Agreement to refrain from resistance training involving the lower extremity muscles on the day before the experiment and to participate in the experiment without performing any exercise on the day of the experiment
- •Agreement to maintain their usual dietary habits throughout the study period
- •No diseases associated with difficulty in stopping bleeding once bleeding occurs
- •No fear of needles or injections
- •No alcohol hypersensitivity
排除标准
- •If the above criteria are not met
研究者
相似试验
招募中
1 期
A Study to Evaluate the Safety and Activity of an Inhaled Investigational Drug (RO7616605) in Healthy Volunteers and Participants With COPDChronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis2025-525042-22-00Genentech Inc.104
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118
尚未招募
不适用
A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)Renal Insufficiency, ChronicjRCT2031260364200